Transcriptional coactivator Drosophila Eyes Absent Homologue 2 is up-regulated in epithelial ovarian cancer and promotes tumor growth

Cancer Research

Volumn 65, Issue 3, 2005, Pages 925-932

  Zhang, Lin ^a,b   Yang, Nuo ^b   Huang, Jia ^a   Buckanovich, Ronald J ^b   Liang, Shun ^b   Barchetti, Andrea ^b   Vezzani, Cristina ^b   O'Brien Jenkins, Ann ^b   Wang, Jennifer ^b   Ward, Michelle Renee ^a   Courreges, Maria C ^b   Fracchioli, Stefano ^b   Medina, Angelica ^a   Katsaros, Dionyssios ^c   Weber, Barbara L ^a   Coukos, George ^a,b,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA;

ARTICLE; CANCER SURGERY; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; DNA HYBRIDIZATION; DROSOPHILA; DROSOPHILA EYES ABSENT HOMOLOGUE 2; GENE; GENE AMPLIFICATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ORGANOGENESIS; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL TIME; TUMOR GROWTH; UPREGULATION; XENOGRAFT;

ANIMALS; CELL GROWTH PROCESSES; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; NUCLEAR PROTEINS; OVARIAN NEOPLASMS; PROGNOSIS; PROTEIN-TYROSINE-PHOSPHATASE; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; UP-REGULATION;

EID: 13444252265     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Wooster R, Weber BL. Breast and ovarian cancer. N Engl J Med 2003;348:2339-47.
2. Zhang L, Conejo-Garcia JR, Katsaros D, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;348:203-13.
3. Bonini NM, Leiserson WM, Benzer S. The eyes absent gene: genetic control of cell survival and differentiation in the developing Drosophila eye. Cell 1993;72:379-95.
4. Pignoni F, Hu B, Zavitz KH, Xiao J, Garrity PA, Zipursky SL. The eye-specification proteins So and Eya form a complex and regulate multiple steps in Drosophila eye development. Cell 1997;91:881-91.
5. Chen R, Amoui M, Zhang Z, Mardon G. Dachshund and eyes absent proteins form a complex and function synergistically to induce ectopic eye development in Drosophila. Cell 1997;91:893-903.
6. Wawersik S, Maas RL. Vertebrate eye development as modeled in Drosophila. Hum Mol Genet 2000;9:917-25.
7. Voas MG, Rebay I. Signal integration during development: insights from the Drosophila eye. Dev Dyn 2004;229:162-75.
8. Hanson IM. Mammalian homologues of the Drosophila eye specification genes. Semin Cell Dev Biol 2001;12:475-84.
9. Bai J, Montell D. Eyes absent, a key repressor of polar cell fate during Drosophila oogenesis. Development 2002;129:5377-88.
10. Fabrizio JJ, Boyle M, DiNardo S. A somatic role for eyes absent (eya) and sine oculis (so) in Drosophila spermatocyte development. Dev Biol 2003;258:117-28.
11. Heanue TA, Reshef R, Davis RJ, et al. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation. Genes Dev 1999;13:3231-43.
12. Xu PX, Cheng J, Epstein JA, Maas RL. Mouse Eya genes are expressed during limb tendon development and encode a transcriptional activation function. Proc Natl Acad Sci U S A 1997;94:11974-9.
13. Li X, Perissi V, Liu F, Rose DW, Rosenfeld MG. Tissue-specific regulation of retinal and pituitary precursor cell proliferation. Science 2002;297:1180-3.
14. Xu PX, Zheng W, Laclef C, et al. Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 2002;129:3033-44.
15. Xu PX, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 1999;23:113-7.
16. Kurusu M, Nagao T, Walldorf U, Flister S, Gehring WJ, Furukubo-Tokunaga K. Genetic control of development of the mushroom bodies, the associative learning centers in the Drosophila brain, by the eyeless, twin of eyeless, and Dachshund genes. Proc Natl Acad Sci U S A 2000;97:2140-4.
17. 2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A 1998;95:12608-13.
18. Coletta RD, Christensen K, Reichenberger KJ, Lamb J, Micomonaco D, Huang L, et al. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A 2004;101:6478-83.
19. Clark SW, Fee BE, Cleveland JL. Misexpression of the eyes absent family triggers the apoptotic program, J Biol Chem 2002;277:3560-7.
20. Abdelhak S, Kalatzis V, Heilig R, et al. A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family. Nat Genet 1997;15:157-64.
21. Bui QT, Zimmerman JE, Liu H, Bonini NM. Molecular analysis of Drosophila eyes absent mutants reveals features of the conserved Eya domain. Genetics 2000;155:709-20.
22. Zimmerman JE, Bui QT, Steingrimsson E, et al. Cloning and characterization of two vertebrate homologs of the Drosophila eyes absent gene. Genome Res 1997;7:128-41.
23. Silver SJ, Davies EL, Doyon L, Rebay I. Functional dissection of eyes absent reveals new modes of regulation within the retinal determination gene network. Mol Cell Biol 2003;23:5989-99.
24. Duncan MK, Kos L, Jenkins NA, Gilbert DJ, Copeland NG, Tomarev SI. Eyes absent: a gene family found in several metazoan phyla. Mamm Genome 1997;8:479-85.
25. Zhang L, Yang N, Park JW, Katsaros D, et al. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 2003;63:3403-12.
26. Zhang L, Yang N, Conejo-Garcia JR, et al. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Clin Cancer Res 2003;9:264-72.
27. Zorn KK, Jazaeri AA, Awtrey CS, et al. Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies. Clin Cancer Res 2003;9:4811-8.
28. Maines-Bandiera SL, Kruk PA, Auersperg N. Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix. Am J Obstet Gynecol 1992;167:729-35.
29. Tsao SW, Mok SC, Fey EG, et al. Characterization of human ovarian surface epithelial cells immortalized by human papilloma viral oncogenes (HPV-E6E7 ORFs). Exp Cell Res 1995;218:499-507.
30. Zhang L, Yang N, Katsaros D, et al. The oncogene phosphatidylinositol 3′-kinase catalytic subunit α promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma. Cancer Res 2003;63:4225-31.
31. Greshock J, Naylor TL, Margolin A, et al. 1-Mb resolution array-based comparative genomic hybridization using a BAC clone set optimized for cancer gene analysis. Genome Res 2004;14:179-87.
32. Sadowski I, Ptashne M. A vector for expressing GAL4(1-147) fusions in mammalian cells. Nucleic Acids Res 1989;17:7539.
33. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
34. Su AI, Welsh JB, Sapinoso LM, et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001;61:7388-93.
35. Iwabuchi H, Sakamoto M, Sakunaga H, et al. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 1995;55:6172-80.
36. Sonoda G, Palazzo J, du Manoir S, et al. Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas. Genes Chromosomes Cancer 1997;20:320-8.
37. Kroll TG, Sarraf P, Pecciarini L, et al. PAX8-PPARγ1 fusion oncogene in human thyroid carcinoma [corrected]. Science 2000;289:1357-60.
38. Chi N, Epstein JA. Getting your Pax straight: Pax proteins in development and disease. Trends Genet 2002;18:41-7.
39. Schaner ME, Ross DT, Ciaravino G, et al. Gene expression patterns in ovarian carcinomas. Mol Biol Cell 2003;14:4376-86.
40. Fee BE, Doyle CA, Cleveland JL. A novel Eyes Absent 2 protein is expressed in the human eye. Gene 2002;285:221-8.
41. Ohto H, Kamada S, Tago K, et al. Cooperation of six and eya in activation of their target genes through nuclear translocation of Eya. Mol Cell Biol 1999;19:6815-24.
42. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G. Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 2004;10:175-81.
43. Tootle TL, Silver SJ, Davies EL, et al. The transcription factor Eyes absent is a protein tyrosine phosphatase. Nature 2003;426:299-302.
44. Li X, Oghi KA, Zhang J, et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature 2003;426:247-54.
45. Rayapureddi JP, Kattamuri C, Steinmetz BD, et al. Eyes absent represents a class of protein tyrosine phosphatases. Nature 2003;426:295-8.